Transdermal CNS drug patches offer the advantages of ease of use, painlessness, disposability, control of drug delivery and avoidance of first-pass metabolism by the liver. Advances in synthetic materials and patch design have led to patches that are more esthetically acceptable and that are capable of delivering sustained dosing of active compounds for several days in a smaller package.
Growth in demand for drug patches is being driven by several factors – factors with strong demographic and population trend underpinnings. Further improvements to transdermal transport and the introduction of new patch designs will keep this segment expanding through 2028
Key Topics Covered:
1. Executive Summary
2. The Market Opportunity
- Transdermal Drug Delivery Dynamics
- Demand Drivers
- Patch Manufacturing Dynamics
- Release Liners
- Backing Films
- Semi-permeable Membranes
- Adhesives
3. Markets for Transdermal CNS Therapeutics
- ADHD
- Daytrana
- Methylphenidate (Daytrana – Noven)
- Alzheimer’s Disease
- Rivastigmine (Exelon – Novartis)
- Aricept Transdermal – Recent Activity
- Exelon
- Depression
- Antidepressants
- Selegiline (EMSAM – Mylan)
- Nausea
- Alkaloids
- Scopolamine (Transderm Scop) GlaxoSmithKline Consumer Health
- Granisetron (Sancuso – ProStrakan)
- Parkinson’s Disease
- Levodopa
- Rotigotine (Neupro – Schwarz/UCB))
- Schizophrenia
- Asenapine (Secuado – Noven)
- Transdermal CNS Drug Product Analysis and Market Assessments
- FDA Approved Transdermal CNS Prescription Products
- CNS Stimulants
- AChE Inhibitors
- Atypical Antipsychotics
- Alkaloids
- Dopamine Agonists
- 5-HT3 Receptor Antagonists
- MAO Inhibitors
4. Strategic Factors and Branding Issues
5. Company Profiles
- Agile
- Allergan
- Alvogen
- Amneal Pharma
- Averitas
- Bayer Healthacere
- Berlex Labs
- Boehringer Inelheim
- Breckenridge
- Corium
- Forest Labs
- Galen Specialty
- GlaxoSmith Klein
- Hisamitsu
- Janssen Pharma
- Kyowa Kirin
- LTS Lohmann
- Mylan Technologies
- Nitto Denko
- Novartis
- Noven
- PurduePharma
- Schwarz
- Scilex Pharms
- Somerset
- Teikoku Pharma USA
- UCB Inc
- US Pharma
- Watson Labs
Source: https://www.businesswire.com/
